Globally the World Health Organization (WHO) estimates the prevalence of Hepatitis C (HCV) is highest in South-East Asia (2.15% or 32.3 million), followed by some countries in Africa (5.3% or 31.9 million) and the Eastern Mediterranean (4.6% or 21.3 million). These statistics are significant when compared to countries in the Americas (1.7% or 13.1 million) and Europe (1.03% or 8.9 million). HCV in Asian Americans is less well characterized than HBV and Stanford University researchers have found that compared to individuals of other racial/ethnic groups, Asian-Americans with chronic HCV infection are more likely to have no identifiable risk factors for contracting the disease.
These findings pose major public health challenges for developing strategies for HCV screening in the culturally diverse Asian American population and the AHC has been incorporating HCV into its HEPP education curriculum.
Below are some user friendly videos created by Vertex Pharmaceuticals and you can also visit their websitehttp://www.bettertoknowc.com/